Cargando…
Analysis of the Role of Variation of Major Histocompatibility Complex Class II Expression on Nonobese Diabetic (NOD) Peripheral T Cell Response
The current paradigm of major histocompatibility complex (MHC) and disease association suggests that efficient binding of autoantigens by disease-associated MHC molecules leads to a T cell–mediated immune response and resultant autoimmune sequelae. The data presented below offer a different model fo...
Autores principales: | Ridgway, William M., Ito, Hiroaki, Fassò, Marcella, Yu, Chen, Garrison Fathman, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212423/ https://www.ncbi.nlm.nih.gov/pubmed/9858513 |
Ejemplares similares
-
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes
Publicado: (1992) -
T Cell Receptor (Tcr)-Mediated Repertoire Selection and Loss of Tcr Vβ Diversity during the Initiation of a Cd4(+) T Cell Response in Vivo
por: Fassò, Marcella, et al.
Publicado: (2000) -
Genetic variation and selection in the major histocompatibility complex Class II gene in the Guizhou pony
por: Liu, Chang, et al.
Publicado: (2020) -
The Marine Mammal Class II Major Histocompatibility Complex Organization
por: de Sá, André Luiz Alves, et al.
Publicado: (2019) -
Major histocompatibility complex Class II-based therapy for stroke
por: Gonzales-Portillo, Bella M., et al.
Publicado: (2021)